Organization
Trillium Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Trillium Therapeutics, Inc.
... Toronto - Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL), a clinical-stage immuno-oncology company developing innovative therapies for the ...
... Toronto - Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL), a clinical-stage immuno-oncology company developing innovative therapies for the ...
... four academic institutions. Key companies operating in this pipeline space include Komipharm, Trillium Therapeutics, AstraZeneca, Insys Therapeutics, Klaria Pharma and Pharmaleads. Bone Metastasis: There are ...
... Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the ...
... Corp. Prior to co-founding XORTX, he was the Chief Scientific Officer of Trillium Therapeutics, formerly Stem Cell Therapeutics Inc. ("Trillium") (NASDAQ:TRIL). XORTX and Trillium are ...
... TORONTO, ONTARIO--(Marketwired - Oct. 11, 2017) - Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the ...
... NASDAQ: TRIL TSX: TRIL Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL),a clinical stage immuno-oncology company developing innovative therapies for the ...
... Trillium Therapeutics Inc. has provided an update on its preclinical small molecule programs. Trillium's ...
... TORONTO, ONTARIO -- (Marketwired) -- 06/28/17 -- Trillium Therapeutics Inc. (TSX:TRIL)(NASDAQ:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the ...
Subscribe now for full coverage on Trillium Therapeutics, Inc.
Start My Free Trial